Answers are grounded in this paper and cite their sources.
Clinical review demonstrates therapeutic benefit of stem cell therapy in non-revascularizable peripheral arterial disease, highlighting its regenerative potential for limb salvage.
Stem cells have demonstrated significant potential for regeneration in peripheral arterial disease in both animal and human studies. While results of clinical trials have been variable, they have clearly displayed benefit for patients with critical limb ischemia and peripheral arterial disease. Because many of these patients are not eligible for revascularization procedures, there is urgent need for novel therapies. A summary of all clinical trials using stem cell therapy in peripheral arterial disease is described herein with the pertinent findings from each study.
No takes yet. Share an insight, caveat, or question.
Taghavi et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: